This Vanguard ETF Tops Schwab in Returns and Cost for Global Investors

Vanguard VEA and Schwab SCHE both offer a ~2.6% dividend yield, but VEA has the lower expense ratio at 0.03% vs. 0.06%. Over the last 12 months (as of 2026-06-30), VEA delivered 28.6% vs. SCHE’s 23.8%, and VEA has slightly edged SCHE over 3 years with more noticeable outperformance over 5 years (VEA growth of ~$1,611 from $1,000 vs. SCHE ~$1,284). The article frames VEA as the more diversified developed-markets option (Europe 48%, Pacific 39%) versus SCHE’s higher concentration risk in tech/semiconductors (top holding ~17% in TSM).

Analysis

The real signal is not “developed vs emerging” so much as quality of exposure. VEA is the cleaner way to express ex-U.S. equity beta because its returns are driven by a broader set of balance sheets and fewer single-name failure points; that tends to attract allocator flows whenever investors want diversification without taking on idiosyncratic China/Taiwan risk. By contrast, SCHE behaves more like a concentrated semiconductor-and-China sentiment vehicle than a true broad EM basket, which makes it more sensitive to one or two macro variables than its label suggests.

That concentration matters for second-order flows: if consultants and model portfolios keep preferring the cheaper, better-diversified developed-market sleeve, the marginal bid goes to European financials, Japanese exporters, and developed-market tech suppliers rather than to China internet or Taiwan-centric exposures. TSM is the key transmission channel here — any disappointment in semiconductor multiples, Taiwan risk premia, or AI capex digestion would hit SCHE harder than the market expects. The flip side is that SCHE can outperform sharply in a weaker dollar / easier-Fed tape because it is effectively leveraged to global cyclicality and semis.

Near term, there is no obvious catalyst to force a re-rating; this is mostly a flow and allocation decision over 1-3 months, with the structural case playing out over 6-18 months. The contrarian point is that the market may be underappreciating how much upside torque SCHE has if TSM and Asia semis re-accelerate; the article’s “lower risk” framing could prove wrong if the next macro leg is EM-friendly. What would falsify a defensive VEA-over-SCHE view is persistent TSM leadership, improving China earnings revisions, or a material USD downtrend that broadens EM performance beyond the concentrated tech names.

Key Decisions for Investors

• Relative-value: long VEA / short SCHE for 3-6 months as a cleaner ex-U.S. allocation trade; thesis works if allocators continue favoring diversified developed-market beta over concentrated EM tech. Falsify if TSM and China internet names regain leadership on improving revisions or a weaker USD.
• If the goal is semiconductor exposure, avoid paying the wrapper risk inside SCHE and buy TSM directly instead of the ETF. SCHE’s concentration means you are effectively taking a Taiwan/semis macro trade with added country noise.
• Tactical watchlist: trim or hedge SCHE on any 5-10% relative outperformance of TSM versus broad EM benchmarks, because that likely indicates the ETF is being driven by one factor rather than broad EM breadth. That is when concentration risk starts to matter most.
• For long-only international allocation, favor VEA as the core sleeve and use smaller satellite positions for EM. The risk/reward is better because fee drag is lower and return dispersion is less hostage to one geopolitical headline.